par Tarabichi, Maxime 
;Demetter, Pieter ;Ruscas-Craciun, Ligia Ioana ;Maenhaut, Carine ;Detours, Vincent
Référence Molecular and cellular endocrinology, 541, page (111491)
Publication Publié, 2021-11-01
;Demetter, Pieter ;Ruscas-Craciun, Ligia Ioana ;Maenhaut, Carine ;Detours, Vincent Référence Molecular and cellular endocrinology, 541, page (111491)
Publication Publié, 2021-11-01
Article révisé par les pairs
| Résumé : | The vast majority of thyroid cancers originate from follicular cells. We outline outstanding issues at each step along the path of cancer patient care, from prevention to post-treatment follow-up and highlight how emerging technologies will help address them in the coming years. Three directions will dominate the coming technological landscape. Genomics will reveal tumoral evolutionary history and shed light on how these cancers arise from the normal epithelium and the genomics alteration driving their progression. Transcriptomics will gain cellular and spatial resolution providing a full account of intra-tumor heterogeneity and opening a window on the microenvironment supporting thyroid tumor growth. Artificial intelligence will set morphological analysis on an objective quantitative ground laying the foundations of a systematic thyroid tumor classification system. It will also integrate into unified representations the molecular and morphological perspectives on thyroid cancer. |
